International Study of Health Care Organization and Financing for end-stage renal disease in France

Int J Health Care Finance Econ. 2007 Sep;7(2-3):171-83. doi: 10.1007/s10754-007-9025-8.

Abstract

The major features of ESRD management in France include the predominance of hemodialysis and the resulting competition for dialysis stations. In 2003, the prevalence of ESRD in France was 0.087%. Of the 52,000 ESRD patients, 30,882 were receiving dialysis and 21,233 had functioning renal transplants. The annual expenditure per ESRD patient in 2003 was estimated at euro40,975. Autodialysis, at euro49,133 per patient per year, was much less expensive than dialyzing in-center at either a public or private facility (euro111,006 and euro75,125, respectively). Transplant activity in France has rapidly increased in recent years, reaching 22 donors per million population in 2005.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Dialysis / economics
  • France / epidemiology
  • Health Expenditures
  • Health Services / economics
  • Health Services / statistics & numerical data
  • Humans
  • International Cooperation
  • Kidney Failure, Chronic / economics*
  • Kidney Failure, Chronic / epidemiology
  • Kidney Failure, Chronic / therapy*
  • Kidney Transplantation / economics
  • National Health Programs / economics
  • National Health Programs / organization & administration*
  • Prevalence
  • Reimbursement Mechanisms